Exploiting the apoptotic route for cancer treatment: a single hit will rarely result in a home run.
de Vries
Elisabeth G E
EG
de Jong
Steven
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009285:Naphthoquinones / Q000008:administration & dosage; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects*; D000077022:Survivin; D016896:Treatment Outcome
C107489:BIRC5 protein, human; D007093:Imidazoles; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009285:Naphthoquinones; D009363:Neoplasm Proteins; D000077022:Survivin; C523798:sepantronium